3.4.21.39 (6E)-4-[(4-chlorophenyl)sulfonyl]-6-(phenylmethylidene)-1,4-diazepane-2,5-dione - 64477 3.4.21.39 (6R)-6-(5-chloro-2-methoxybenzyl)-4-[(4-chlorophenyl)sulfonyl]-1,4-diazepane-2,5-dione - 66429 3.4.21.39 (6S)-6-(5-chloro-2-methoxybenzyl)-4-[(4-chlorophenyl)sulfonyl]-1,4-diazepane-2,5-dione potent inhibitor 66428 3.4.21.39 1-(2-Amino-3-methyl-butyryl)-pyrrolidine-2-carboxylic acid (1-benzyl-3,3,3-trifluoro-2-oxo-propyl)-amide - 22953 3.4.21.39 1-[(5-fluoro-1-benzothiophen-3-yl)methyl]-3-{[(methoxycarbonyl)(methyl)amino]methyl}-1H-indole-2-carboxylate - 200422 3.4.21.39 2-(2-[2-[5-amino-2-(3-amino-phenyl)-6-oxo-6H-pyrimidin-1-yl]-acetylamido]-3-phenyl-propionyl)-benzooxazole-5-carboxylic acid methyl ester - 123129 3.4.21.39 2-(2-[2-[5-amino-2-(3-methoxy-phenyl)-6-oxo-6H-pyrimidin-1-yl]-acetylamido]-3-phenyl-propionyl)-benzooxazole-5-carboxylic acid methyl ester i.e. Y40079, novel, potent and orally active chymase inhibitor which would be a useful tool in elucidating the pathophysiological roles of chymase 123128 3.4.21.39 2-(2-[2-[5-amino-2-(3-nitro-phenyl)-6-oxo-6H-pyrimidin-1-yl]-acetylamido]-3-phenyl-propionyl)-benzooxazole-5-carboxylic acid methyl ester - 56046 3.4.21.39 2-(2-{2-[5-amino-2-(3-amino-phenyl)-6-oxo-6H-pyrimidin-1-yl]-acetylamido}-3-phenyl-propionyl)-benzooxazole-5-carboxylic acid methyl ester - 119058 3.4.21.39 2-(2-{2-[5-amino-2-(3-chloro-phenyl)-6-oxo-6H-pyrimidin-1-yl]-acetylamido}-3-phenyl-propionyl)-benzooxazole-5-carboxylic acid methyl ester - 119055 3.4.21.39 2-(2-{2-[5-amino-2-(3-fluoro-phenyl)-6-oxo-6H-pyrimidin-1-yl]-acetylamido}-3-phenyl-propionyl)-benzooxazole-5-carboxylic acid methyl ester - 119054 3.4.21.39 2-(2-{2-[5-amino-2-(3-nitro-phenyl)-6-oxo-6H-pyrimidin-1-yl]-acetylamido}-3-phenyl-propionyl)-benzooxazole-5-carboxylic acid methyl ester - 119057 3.4.21.39 2-(2-{2-[5-amino-2-(4-fluoro-phenyl)-6-oxo-6H-pyrimidin-1-yl]-acetylamido}-3-phenyl-propionyl)-benzooxazol-5-carboxylic acid diethylamide - 119051 3.4.21.39 2-(2-{2-[5-amino-2-(4-fluoro-phenyl)-6-oxo-6H-pyrimidin-1-yl]-acetylamido}-3-phenyl-propionyl)-benzooxazol-5-carboxylic acid ethyl ester - 119049 3.4.21.39 2-(2-{2-[5-amino-2-(4-fluoro-phenyl)-6-oxo-6H-pyrimidin-1-yl]-acetylamido}-3-phenyl-propionyl)-benzooxazol-5-carboxylic acid ethylamide - 119050 3.4.21.39 2-(2-{2-[5-amino-2-(4-fluoro-phenyl)-6-oxo-6H-pyrimidin-1-yl]-acetylamido}-3-phenyl-propionyl)-benzooxazol-6-carboxylic acid methyl ester - 119052 3.4.21.39 2-(2-{2-[5-amino-2-(4-fluoro-phenyl)-6-oxo-6H-pyrimidin-1-yl]-acetylamido}-3-phenyl-propionyl)-benzooxazole-5-carboxylic acid methyl ester - 119048 3.4.21.39 2-(5-Acetylamino-6-oxo-2-phenyl-1,6-dihydro-1-pyrimidinyl)-N-(1-benzyl-3,3,3-trifluoro-2-oxopropyl)acetamide - 55259 3.4.21.39 2-(5-Amino-6-oxo-1,6-dihydro-1-pyrimidinyl)-N-(1-benzyl-3,3,3-trifluoro-2-oxopropyl)acetamide - 55244 3.4.21.39 2-(5-Amino-6-oxo-2-phenyl-1,6-dihydro-1-pyrimidinyl)-N-(1-benzyl-3,3,3-trifluoro-2-hydroxypropyl)acetamide - 55238 3.4.21.39 2-(5-Amino-6-oxo-2-phenyl-1,6-dihydro-1-pyrimidinyl)-N-(1-benzyl-3,3,3-trifluoro-2-oxopropyl)acetamide - 55237 3.4.21.39 2-(5-amino-6-oxo-2-phenyl-1,6-dihydro-1-pyrimidinyl)-N-(2-phenethyl)acetamide - 55240 3.4.21.39 2-(5-amino-6-oxo-2-phenyl-1,6-dihydro-1-pyrimidinyl)-N-methylacetamide - 55239 3.4.21.39 2-(5-Benzenesulfonylamino-6-oxo-2-phenyl-1,6-dihydro-1-pyrimidinyl)-N-(1-benzyl-3,3,3-trifluoro-2-oxopropyl)acetamide - 55266 3.4.21.39 2-(5-Benzoylamino-6-oxo-2-phenyl-1,6-dihydro-1-pyrimidinyl)-N-(1-benzyl-3,3,3-trifluoro-2-oxopropyl)acetamide - 55260 3.4.21.39 2-(5-Benzyloxycarbonylamino-6-oxo-2-phenyl-1,6-dihydro-1-pyrimidinyl)-N-(1-benzyl-3,3,3-trifluoro-2-oxopropyl)acetamide - 55258 3.4.21.39 2-(5-formylamino-6-oxo-2-phenyl-1,6-dihydropyrimidine-1-yl)-N-[[3,4-dioxo-1-phenyl-7-(2-pyridyloxy)]-2-heptyl]acetamide NK3201 39035 3.4.21.39 2-(5-formylamino-6-oxo-2-phenyl-1,6-dihydropyrimidine-1-yl)-N-[[3,4-dioxo-1-phenyl-7-(2-pyridyloxy)]-heptyl] acetamide NK3201 14198 3.4.21.39 2-(5-Hydroxysuccinylamino-6-oxo-2-phenyl-1,6-dihydro-1-pyrimidinyl)-N-(1-benzyl-3,3,3-trifluoro-2-oxopropyl)acetamide - 55263 3.4.21.39 2-(5-Mehoxysuccinylamino-6-oxo-2-phenyl-1,6-dihydro-1-pyrimidinyl)-N-(1-benzyl-3,3,3-trifluoro-2-oxopropyl)acetamide - 55261 3.4.21.39 2-(5-Methanesulfonylamino-6-oxo-2-phenyl-1,6-dihydro-1-pyrimidinyl)-N-(1-benzyl-3,3,3-trifluoro-2-oxopropyl)acetamide - 55265 3.4.21.39 2-(5-Oxaloamino-6-oxo-2-phenyl-1,6-dihydro-1-pyrimidinyl)-N-(1-benzyl-3,3,3-trifluoro-2-oxopropyl)acetamide - 55262 3.4.21.39 2-(benzylamino)-4H-3,1-benzoxazin-4-one - 56039 3.4.21.39 2-(benzyloxycarbonyl-NH(CH2)2CONH)C6H4SO2F - 31295 3.4.21.39 2-(benzyloxycarbonyl-NH(CH2)5CONH)C6H4SO2F - 46950 3.4.21.39 2-(benzyloxycarbonyl-NHCH2CONH)C6H4SO2F - 31296 3.4.21.39 2-(N-benzyl-N-methylamino)-4H-3,1-benzoxazin-4-one inhibitor forms a stable acyl-enzyme with half-life of 53 min 56035 3.4.21.39 2-(N-benzyl-N-methylamino)-6-methyl-4H-3,1-benzoxazin-4-one - 56038 3.4.21.39 2-(N-methyl-N-phenylamino)-4H-3,1-benzoxazin-4-one inhibitor forms a stable acyl-enzyme with half-life of 25 min 56036 3.4.21.39 2-amino-4-[(1R)-1-([(6R)-6-[(5-chloro-2-methoxyphenyl)methyl]-3,7-dioxo-1,4-diazepane-1-carbonyl]amino)propyl]benzoic acid - 236039 3.4.21.39 2-amino-4-[(1R)-1-([[(6R)-6-(5-chloro-2-methoxybenzyl)-3,7-dioxo-1,4-diazepan-1-yl]carbonyl]amino)propyl]benzoic acid - 36805 3.4.21.39 2-amino-4-[(1R)-1-([[(6S)-6-(5-chloro-2-methoxybenzyl)-3,7-dioxo-1,4-diazepan-1-yl]carbonyl]amino)propyl]benzoic acid - 24732 3.4.21.39 2-amino-4-[(1R)-1-[[(3E,6R)-6-[(5-chloro-2-methoxyphenyl)methyl]-3-(ethoxyimino)-7-oxo-1,4-diazepane-1-carbonyl]amino]propyl]benzoic acid - 236040 3.4.21.39 2-amino-4-[(1R)-1-[[(3E,6R)-6-[(5-chloro-2-methoxyphenyl)methyl]-7-oxo-3-(phenoxyimino)-1,4-diazepane-1-carbonyl]amino]propyl]benzoic acid - 236041 3.4.21.39 2-amino-5-[(1R)-1-([[(6R)-6-(5-chloro-2-methoxybenzyl)-3,7-dioxo-1,4-diazepan-1-yl]carbonyl]amino)propyl]benzoic acid - 18351 3.4.21.39 2-[2-(4-Fluorophenyl)-5-hydroxysuccinylamino-6-oxo-2-phenyl-1,6-dihydro-1-pyrimidinyl]-N-(1-benzyl-3,3,3-trifluoro-2-oxopropyl)acetamide - 55264 3.4.21.39 2-[2-[2-(5-amino-6-oxo-2-m-tolyl-6H-pyrimidin-1-yl)-acetylamino]-3-phenyl-propionyl]-benzooxazole-5-carboxylic acid methyl ester - 34618 3.4.21.39 2-[2-[2-(5-amino-6-oxo-2-phenyl-6H-pyrimidin-1-yl)-acetylamino]-3-phenyl-propionyl]-benzooxazole-5-carboxylic acid methyl ester - 34617 3.4.21.39 2-[2-[2-(5-amino-6-oxo-2-pyridin-3-yl-6H-pyrimidin-1-yl)-acetylamino]-3-phenyl-propionyl]-benzooxazole-5-carboxylic acid methyl ester - 34619 3.4.21.39 2-[2-[2-(5-amino-6-oxo-2-pyridin-4-yl-6H-pyrimidin-1-yl)-acetylamino]-3-phenyl-propionyl]-benzooxazole-5-carboxylic acid methyl ester - 34620 3.4.21.39 2-[2-[2-[5-amino-2-(3-chloro-phenyl)-6-oxo-6H-pyrimidin-1-yl]-acetylamido]-3-phenyl-propionyl]-benzooxazole-5-carboxylic acid methyl ester - 56045 3.4.21.39 2-[2-[2-[5-amino-2-(3-fluoro-phenyl)-6-oxo-6H-pyrimidin-1-yl]-acetylamido]-3-phenyl-propionyl]-benzooxazole-5-carboxylic acid methyl ester - 56044 3.4.21.39 2-[2-[2-[5-amino-2-(3-methoxy-phenyl)-6-oxo-6H-pyrimidin-1-yl]-acetylamido]-3-phenyl-propionyl]-benzooxazole-5-carboxylic acid methyl ester i.e. Y40079, novel, potent and orally active chymase inhibitor which would be a useful tool in elucidating the pathophysiological roles of chymase 8569 3.4.21.39 2-[2-[2-[5-amino-2-(3-methoxy-phenyl)-6-oxo-6H-pyrimidin-1-yl]-acetylamido]-3-phenyl-propionyl]-benzooxazole-5-carboxylic acid methyl ester - 8569 3.4.21.39 2-[2-[2-[5-amino-2-(3-nitro-phenyl)-6-oxo-6H-pyrimidin-1-yl]-acetylamido]-3-phenyl-propionyl]-benzooxazole-5-carboxylic acid methyl ester - 56397 3.4.21.39 2-[2-[2-[5-amino-2-(4-fluoro-phenyl)-6-oxo-6H-pyrimidin-1-yl]-acetylamido]-3-phenyl-propionyl]-benzooxazol-5-carboxylic acid diethylamide - 56042 3.4.21.39 2-[2-[2-[5-amino-2-(4-fluoro-phenyl)-6-oxo-6H-pyrimidin-1-yl]-acetylamido]-3-phenyl-propionyl]-benzooxazol-5-carboxylic acid ethyl ester - 56040 3.4.21.39 2-[2-[2-[5-amino-2-(4-fluoro-phenyl)-6-oxo-6H-pyrimidin-1-yl]-acetylamido]-3-phenyl-propionyl]-benzooxazol-5-carboxylic acid ethylamide - 56041 3.4.21.39 2-[2-[2-[5-amino-2-(4-fluoro-phenyl)-6-oxo-6H-pyrimidin-1-yl]-acetylamido]-3-phenyl-propionyl]-benzooxazol-6-carboxylic acid methyl ester - 56043 3.4.21.39 2-[2-[2-[5-amino-2-(4-fluoro-phenyl)-6-oxo-6H-pyrimidin-1-yl]-acetylamido]-3-phenyl-propionyl]-benzooxazole-5-carboxylic acid methyl ester - 9788 3.4.21.39 2-[4-(5-fluoro-3-methylbenzo[b] thiophen-2-yl)sulfonamido-3-methansulfonylphenyl]oxazole-4-carboxylic acid TY-1184 14199 3.4.21.39 2-[4-(5-fluoro-3-methylbenzo[b]thiophen-2-yl)sulfonamido-3-methanesulfonylphenyl]thiazole-4-carboxylic acid TY-51469, specific chymase inhibitor 159906 3.4.21.39 2-[4-chloro-2-([1-[(4-chlorophenyl)sulfonyl]-3,7-dioxo-1,4-diazepan-6-yl]methyl)phenoxy]-N-methylacetamide - 64626 3.4.21.39 2-[5-Amino-2-(3-chlorophenyl)-6-oxo-1,6-dihydro-1-pyrimidinyl]-N-(1-benzyl-3,3,3-trifluoro-2-oxopropyl)acetamide - 55247 3.4.21.39 2-[5-Amino-2-(3-fluorophenyl)-6-oxo-1,6-dihydro-1-pyrimidinyl]-N-(1-benzyl-3,3,3-trifluoro-2-oxopropyl)acetamide - 55245 3.4.21.39 2-[5-Amino-2-(4-aminophenyl)-6-oxo-1,6-dihydro-1-pyrimidinyl]-N-(1-benzyl-3,3,3-trifluoro-2-oxopropyl)acetamide - 55254 3.4.21.39 2-[5-Amino-2-(4-chlorophenyl)-6-oxo-1,6-dihydro-1-pyrimidinyl]-N-(1-benzyl-3,3,3-trifluoro-2-oxopropyl)acetamide - 55248 3.4.21.39 2-[5-Amino-2-(4-fluoro-phenyl)-6-oxo-6H-pyrimidin-1-yl]-N-(1-benzyl-2-oxazolo[4,5-b]pyridin-2-yl-2-oxo-ethyl)-acetamide - 55268 3.4.21.39 2-[5-Amino-2-(4-fluoro-phenyl)-6-oxo-6H-pyrimidin-1-yl]-N-(1-benzyl-2-oxo-2-thiazol-2-yl-ethyl)-acetamide - 2912 3.4.21.39 2-[5-Amino-2-(4-fluoro-phenyl)-6-oxo-6H-pyrimidin-1-yl]-N-(2-benzothiazol-2-yl-1-benzyl-2-oxo-ethyl)-acetamide - 55267 3.4.21.39 2-[5-Amino-2-(4-fluoro-phenyl)-6-oxo-6H-pyrimidin-1-yl]-N-[1-benzyl-2-(4,5-dihydro-oxazol-2-yl)-2-oxo-ethyl]-acetamide - 55243 3.4.21.39 2-[5-Amino-2-(4-fluoro-phenyl)-6-oxo-6H-pyrimidin-1-yl]-N-[1-benzyl-2-(5-fluoro-benzooxazol-2-yl)-2-oxo-ethyl]-acetamide - 22948 3.4.21.39 2-[5-Amino-2-(4-fluoro-phenyl)-6-oxo-6H-pyrimidin-1-yl]-N-[1-benzyl-2-(5-methoxy-benzooxazol-2-yl)-2-oxo-ethyl]-acetamide - 22949 3.4.21.39 2-[5-Amino-2-(4-fluoro-phenyl)-6-oxo-6H-pyrimidin-1-yl]-N-[1-benzyl-2-oxo-2-(5-phenyl-benzooxazol-2-yl)-ethyl]-acetamide - 22950 3.4.21.39 2-[5-Amino-2-(4-fluorophenyl)-6-oxo-1,6-dihydro-1-pyrimidinyl]-N-(1-benzyl-3,3,3-trifluoro-2-oxopropyl)acetamide - 55246 3.4.21.39 2-[5-Amino-2-(4-fluorophenyl)-6-oxo-1,6-dihydro-1-pyrimidinyl]-N-[1-[(2-benzoxazolyl)carbonyl]-2-phenylethyl]-acetamide - 22947 3.4.21.39 2-[5-Amino-2-(4-fluorophenyl)-6-oxo-1,6-dihydro-1-pyrimidinyl]-N-[1-[(5-aminobenzoxazol-2-yl)carbonyl]-2-phenylethyl]acetamide - 55234 3.4.21.39 2-[5-Amino-2-(4-fluorophenyl)-6-oxo-1,6-dihydro-1-pyrimidinyl]-N-[1-[(5-carbamoylbenzoxazol-2-yl)carbonyl]-2-phenylethyl]acetamide - 22952 3.4.21.39 2-[5-Amino-2-(4-fluorophenyl)-6-oxo-1,6-dihydro-1-pyrimidinyl]-N-[1-[(5-carboxybenzoxazol-2-yl)carbonyl]-2-phenylethyl]acetamide - 22951 3.4.21.39 2-[5-Amino-2-(4-fluorophenyl)-6-oxo-1,6-dihydro-1-pyrimidinyl]-N-[1-[(5-hydroxybenzoxazol-2-yl)carbonyl]-2-phenylethyl]acetamide - 17565 3.4.21.39 2-[5-Amino-2-(4-hydroxyphenyl)-6-oxo-1,6-dihydro-1-pyrimidinyl]-N-(1-benzyl-3,3,3-trifluoro-2-oxopropyl)acetamide - 55252 3.4.21.39 2-[5-Amino-2-(4-methoxyphenyl)-6-oxo-1,6-dihydro-1-pyrimidinyl]-N-(1-benzyl-3,3,3-trifluoro-2-oxopropyl)acetamide - 55251 3.4.21.39 2-[5-Amino-2-(4-nitrophenyl)-6-oxo-1,6-dihydro-1-pyrimidinyl]-N-(1-benzyl-3,3,3-trifluoro-2-oxopropyl)acetamide - 55253 3.4.21.39 2-[5-Amino-6-oxo-2-(2-thienyl)-1,6-dihydro-1-pyrimidinyl]-N-(1-benzyl-3,3,3-trifluoro-2-oxopropyl)acetamide - 55257 3.4.21.39 2-[5-Amino-6-oxo-2-(3-pyridyl)-1,6-dihydro-1-pyrimidinyl]-N-(1-benzyl-3,3,3-trifluoro-2-oxopropyl)acetamide - 55255 3.4.21.39 2-[5-Amino-6-oxo-2-(4-pyridyl)-1,6-dihydro-1-pyrimidinyl]-N-(1-benzyl-3,3,3-trifluoro-2-oxopropyl)acetamide - 55256 3.4.21.39 2-[5-Amino-6-oxo-2-(m-tolyl)-1,6-dihydro-1-pyrimidinyl]-N-(1-benzyl-3,3,3-trifluoro-2-oxopropyl)acetamide - 55249 3.4.21.39 2-[5-Amino-6-oxo-2-(p-tolyl)-1,6-dihydro-1-pyrimidinyl]-N-(1-benzyl-3,3,3-trifluoro-2-oxopropyl)acetamide - 55250 3.4.21.39 2-{1-[(1,4-dimethyl-1H-indol-3-yl)methyl]-2,4-dioxo-1,4-dihydroquinazolin-3(2H)-yl}hexanoic acid - 200423 3.4.21.39 2-{2-[2-(5-Amino-6-oxo-2-m-tolyl-6H-pyrimidin-1-yl)-acetylamino]-3-phenyl-propionyl}-benzooxazole-5-carboxylic acid methyl ester - 119056 3.4.21.39 2-{2-[2-(5-Amino-6-oxo-2-phenyl-6H-pyrimidin-1-yl)-acetylamino]-3-phenyl-propionyl}-benzooxazole-5-carboxylic acid methyl ester - 119053 3.4.21.39 2-{2-[2-(5-Amino-6-oxo-2-pyridin-3-yl-6H-pyrimidin-1-yl)-acetylamino]-3-phenyl-propionyl}-benzooxazole-5-carboxylic acid methyl ester novel, potent, and orally active inhibitor. Rapidly after oral administration and has satisfactory bioavailability 119059 3.4.21.39 2-{2-[2-(5-Amino-6-oxo-2-pyridin-4-yl-6H-pyrimidin-1-yl)-acetylamino]-3-phenyl-propionyl}-benzooxazole-5-carboxylic acid methyl ester - 119060 3.4.21.39 3,4-dichloroisocoumarin - 1040 3.4.21.39 3-([1-[(4-chlorophenyl)sulfonyl]-3,7-dioxo-1,4-diazepan-6-yl]methyl)-4-methoxybenzonitrile - 64644 3.4.21.39 3-C6H5CONHC6H4SO2F - 46965 3.4.21.39 3-CF3C6H4SO2F - 46966 3.4.21.39 3-[(1R)-1-([[(6R)-6-(5-chloro-2-methoxybenzyl)-3,7-dioxo-1,4-diazepan-1-yl]carbonyl]amino)propyl]benzoic acid - 36811 3.4.21.39 3-[(1R)-1-([[(6S)-6-(5-chloro-2-methoxybenzyl)-3,7-dioxo-1,4-diazepan-1-yl]carbonyl]amino)propyl]benzoic acid - 36812 3.4.21.39 3-[(3,4-dimethoxyphenyl)sulfonyl]-1-(3,4-dimethylphenyl)imidazoline-2,4-dione C41 39034 3.4.21.39 3-[(3-amino-4-carboxy)phenylsulfonyl]-7-chloroquinazorine SUNC8257 66430 3.4.21.39 3-[5-Amino-6-oxo-2-(m-tolyl)-1,6-dihydro-1-pyrimidinyl]-N-(1-benzyl-3,3,3-trifluoro-2-oxopropyl)propanamide - 55242 3.4.21.39 3[(3-amino-4-carboxy) phenylsulfonyl]-7-chloroquinazolone-2,4(1H,3H)-dione N-C8257 37016 3.4.21.39 4-({1-[(4-methyl-1-benzothiophen-3-yl)methyl]-1H-benzimidazol-2-yl}sulfanyl)butanoic acid - 200420 3.4.21.39 4-[(1R)-1-([(3E,6R)-6-[(5-chloro-2-methoxyphenyl)methyl]-3-[(2-methylpropoxy)imino]-7-oxo-1,4-diazepane-1-carbonyl]amino)propyl]benzoic acid - 236245 3.4.21.39 4-[(1R)-1-([(3E,6R)-6-[(5-chloro-2-methoxyphenyl)methyl]-3-[(cyclopentyloxy)imino]-7-oxo-1,4-diazepane-1-carbonyl]amino)propyl]benzoic acid - 236246 3.4.21.39 4-[(1R)-1-([(6R)-6-[(5-chloro-2-methoxyphenyl)methyl]-3,7-dioxo-1,4-diazepane-1-carbonyl]amino)propyl]benzoic acid - 236247 3.4.21.39 4-[(1R)-1-([[(6R)-6-(5-chloro-2-methoxybenzyl)-3,7-dioxo-1,4-diazepan-1-yl]carbonyl]amino)propyl]-2-hydroxybenzoic acid - 36817 3.4.21.39 4-[(1R)-1-([[(6R)-6-(5-chloro-2-methoxybenzyl)-3,7-dioxo-1,4-diazepan-1-yl]carbonyl]amino)propyl]benzoic acid - 24749 3.4.21.39 4-[(1R)-1-[[(3E,6R)-6-[(5-chloro-2-methoxyphenyl)methyl]-3-(ethoxyimino)-7-oxo-1,4-diazepane-1-carbonyl]amino]propyl]benzoic acid - 236248 3.4.21.39 4-[(1R)-1-[[(3E,6R)-6-[(5-chloro-2-methoxyphenyl)methyl]-7-oxo-3-(phenoxyimino)-1,4-diazepane-1-carbonyl]amino]propyl]benzoic acid - 236249 3.4.21.39 4-[(1R)-1-[[(3E,6R)-6-[(5-chloro-2-methoxyphenyl)methyl]-7-oxo-3-[[(propan-2-yl)oxy]imino]-1,4-diazepane-1-carbonyl]amino]propyl]benzoic acid - 236250 3.4.21.39 4-[(4-chlorophenyl)sulfonyl]-1,4-diazepane-2,5-dione - 64694 3.4.21.39 4-[(4-chlorophenyl)sulfonyl]-6-(2,5-dimethoxybenzyl)-1,4-diazepane-2,5-dione - 64695 3.4.21.39 4-[(4-chlorophenyl)sulfonyl]-6-(2-ethoxybenzyl)-1,4-diazepane-2,5-dione - 64696 3.4.21.39 4-[(4-chlorophenyl)sulfonyl]-6-(2-fluorobenzyl)-1,4-diazepane-2,5-dione - 64697 3.4.21.39 4-[(4-chlorophenyl)sulfonyl]-6-(2-methoxybenzyl)-1,4-diazepane-2,5-dione - 64698 3.4.21.39 4-[(4-chlorophenyl)sulfonyl]-6-(4,5-dichloro-2-methoxybenzyl)-1,4-diazepane-2,5-dione - 64699 3.4.21.39 4-[(4-chlorophenyl)sulfonyl]-6-(5-chloro-2-propoxybenzyl)-1,4-diazepane-2,5-dione - 64700 3.4.21.39 4-[(4-chlorophenyl)sulfonyl]-6-(5-fluoro-2-methoxybenzyl)-1,4-diazepane-2,5-dione - 64701 3.4.21.39 4-[(4-chlorophenyl)sulfonyl]-6-(5-hydroxy-2-methoxybenzyl)-1,4-diazepane-2,5-dione - 64702 3.4.21.39 4-[(4-chlorophenyl)sulfonyl]-6-(cyclohexylmethyl)-1,4-diazepane-2,5-dione - 64703 3.4.21.39 4-[(4-chlorophenyl)sulfonyl]-6-(naphthalen-2-ylmethyl)-1,4-diazepane-2,5-dione - 64704 3.4.21.39 4-[(4-chlorophenyl)sulfonyl]-6-(pyridin-3-ylmethyl)-1,4-diazepane-2,5-dione - 64705 3.4.21.39 4-[(4-chlorophenyl)sulfonyl]-6-(pyridin-4-ylmethyl)-1,4-diazepane-2,5-dione - 64706 3.4.21.39 4-[1-(naphthylmethyl)benzimidazol-2-ylthio]butanoic acid TEI-E548 39036 3.4.21.39 4-[1-[bis-(4-methyl-phenyl)-methyl]-carbamoyl]-3-(2-ethoxy-benzyl)-4-oxo-azetidine-2-yloxy-benzoic acid BCEAB 25043 3.4.21.39 4-[1-[[bis-(4-methyl-phenyl)-methyl]-carbamoyl]-3-(2-ethoxy-benzyl)-4-oxo-azetidine-2-yloxy]-benzoic acid - 39032 3.4.21.39 5-fluoresceinylthiocarbamoyl-Ala-Ala-Met phosphonate diphenyl ester - 99901 3.4.21.39 5-hydroxytryptamine - 1669 3.4.21.39 5-[(1R)-1-([[(6R)-6-(5-chloro-2-methoxybenzyl)-3,7-dioxo-1,4-diazepan-1-yl]carbonyl]amino)propyl]-2-hydroxybenzoic acid - 64735 3.4.21.39 6-(2-butoxy-5-chlorobenzyl)-4-[(4-chlorophenyl)sulfonyl]-1,4-diazepane-2,5-dione - 64739 3.4.21.39 6-(2-chlorobenzyl)-4-[(4-chlorophenyl)sulfonyl]-1,4-diazepane-2,5-dione - 64740 3.4.21.39 6-(3-chloro-5-fluoro-2-methoxybenzyl)-4-[(4-chlorophenyl)sulfonyl]-1,4-diazepane-2,5-dione - 64741 3.4.21.39 6-(3-chlorobenzyl)-4-[(4-chlorophenyl)sulfonyl]-1,4-diazepane-2,5-dione - 64742 3.4.21.39 6-(4-chlorobenzyl)-4-[(4-chlorophenyl)sulfonyl]-1,4-diazepane-2,5-dione - 64744 3.4.21.39 6-(5-chloro-2-ethoxybenzyl)-4-[(4-chlorophenyl)sulfonyl]-1,4-diazepane-2,5-dione - 64745 3.4.21.39 6-(5-chloro-2-methoxybenzyl)-3,7-dioxo-N-(1-phenylbutyl)-1,4-diazepane-1-carboxamide - 64746 3.4.21.39 6-(5-chloro-2-methoxybenzyl)-3,7-dioxo-N-(1-phenylethyl)-1,4-diazepane-1-carboxamide - 64747 3.4.21.39 6-(5-chloro-2-methoxybenzyl)-3,7-dioxo-N-(1-phenylpropyl)-1,4-diazepane-1-carboxamide - 64748 3.4.21.39 6-(5-chloro-2-methoxybenzyl)-3,7-dioxo-N-(2-phenylethyl)-1,4-diazepane-1-carboxamide - 64749 3.4.21.39 6-(5-chloro-2-methoxybenzyl)-4-[(4-chlorophenyl)sulfonyl]-1,4-diazepane-2,5-dione - 64750 3.4.21.39 6-(5-chloro-2-methoxybenzyl)-N-(2-methyl-1-phenylpropyl)-3,7-dioxo-1,4-diazepane-1-carboxamide - 64751 3.4.21.39 6-(5-chloro-2-methoxybenzyl)-N-(diphenylmethyl)-3,7-dioxo-1,4-diazepane-1-carboxamide - 64752 3.4.21.39 6-benzyl-4-[(4-chlorophenyl)sulfonyl]-1,4-diazepane-2,5-dione - 64753 3.4.21.39 6-methyl-2-(N-methyl-N-phenylamino)-4H-3,1-benzoxazin-4-one - 56037 3.4.21.39 acetyl-Ala-Gly-Phe-CH2Cl - 47013 3.4.21.39 alpha1-Aantichymotrypsin - 2590 3.4.21.39 alpha1-Aantichymotrypsin native chymase-heparin proteoglycan complex is largely resistant to inhibition by alpha1-antichymotrypsin 2590 3.4.21.39 alpha1-antitrypsin - 1571 3.4.21.39 alpha1-antitrypsin partial 1571 3.4.21.39 Alpha1-proteinase inhibitor - 3381 3.4.21.39 antichymotrypsin - 66431 3.4.21.39 antileukoprotease HUSI-I 21085 3.4.21.39 antipain - 520 3.4.21.39 antipain partial 520 3.4.21.39 antitrypsin - 139020 3.4.21.39 Aprotinin - 405 3.4.21.39 Aprotinin partial 405 3.4.21.39 benzyloxycarbonyl-Gly-Leu-Phe-chloromethyl ketone - 30949 3.4.21.39 benzyloxycarbonyl-Ile-Glu-Pro-Phe-COOCH3 - 100251 3.4.21.39 benzyloxycarbonyl-Leu-Phe-chloromethyl ketone - 47121 3.4.21.39 bestatin - 225 3.4.21.39 beta-boswellic acid - 24555 3.4.21.39 biotinyl-6-aminocaproyl-6-aminocaproyl-Phe-Leu-Phe-phosphonate phenyl ester - 100317 3.4.21.39 C6H5CH2SO3F - 47142 3.4.21.39 chymostatin - 511 3.4.21.39 chymostatin [(S)-1-carboxy-2-phenylethyl]-carbamoyl-alpha-[2-iminohexahydro-4(S)-pyrimidyl]-(S)-Gly-X-Phe-al, X can be the amino acid Leu, Val, or Ile, nonspecific chymase inhibitor 511 3.4.21.39 chymostatin i.e. (S)-1-carboxy-2-(phenylethyl)-carbamoyl-alpha-[2-iminohexahydro-4(S)-pyrimidyl]-(S)-glycyl-X-phenylalaninal 511 3.4.21.39 chymostatin 80 ng/ml chymase is significantly inhibited by 0.015 mM chymostatin. 80% inhibition at 0.05 mM 511 3.4.21.39 decanoyl lysophosphatidic acid - 100444 3.4.21.39 diisopropyl fluorophosphate - 244 3.4.21.39 dilauroyl phosphatidic acid - 100470 3.4.21.39 dioleoyl phosphatidic acid - 12971 3.4.21.39 dipalmitoyl phosphatidic acid - 47201 3.4.21.39 dipyridyl IC50: above 0.4 mM 12878 3.4.21.39 distearoyl phosphatidic acid - 47203 3.4.21.39 Eglin c potent inhibitor 2653 3.4.21.39 Eglin c - 2653 3.4.21.39 elaidic acid - 5674 3.4.21.39 fatty acids carbon chain length of 14-22 2739 3.4.21.39 ginkgolic acid - 67281 3.4.21.39 JNJ-10311795 - 17851 3.4.21.39 JNJ-10311795 i.e. 2-[3-[methyl[1-(2-naphthoyl) piperidin-4-yl]amino]carbonyl-2-naphthyl]-1-(1-naphthyl)-2-oxoethylphosphonic acid 17851 3.4.21.39 keto-betaboswellic acid - 239590 3.4.21.39 ketotifen - 11776 3.4.21.39 L-1-tosylamide-2-phenyl-ethylchloromethyl ketone - 97355 3.4.21.39 L-Valyl-N-(1-benzyl-3,3,3-trifluoro-2-oxopropyl)-L-prolinamide hydrochloride - 55236 3.4.21.39 linoleic acid - 428 3.4.21.39 linolenic acid - 1413 3.4.21.39 lisinopril IC50: above 0.4 mM 1281 3.4.21.39 methyl 3-[(1R)-1-([[(6R)-6-(5-chloro-2-methoxybenzyl)-3,7-dioxo-1,4-diazepan-1-yl]carbonyl]amino)propyl]benzoate - 36827 3.4.21.39 methyl[1-naphthalen-2-yl-2-(naphthalen-2-ylamino)-2-oxoethyl]phosphinic acid - 64853 3.4.21.39 additional information not affected by heparin 2 3.4.21.39 additional information not inhibited by captopril 2 3.4.21.39 additional information not inhibited by phosphoramidon 2 3.4.21.39 additional information both the nonpolar hydrophobic hydrocarbon tails and the polar hydrophilic head are essential for the inhibitory effect of phosphoglycerides 2 3.4.21.39 additional information endogenous mast cell heparin proteoglycan significantly blocks the inhibition of the enzyme by the serpins alpha1-protease inhibitor and alpha1-antichymotrypsin as well as the inhibition by alpha2-macroglobulin, soybean trypsin inhibitor and plasma. Native chymase-heparin proteoglycan complex is largely resistant to inhibition by alpha1-antichymotrypsin and alpha1-protease inhibitor 2 3.4.21.39 N-(1-Benzyl-3,3,3-trifluoro-2-oxopropyl)acetamide - 55241 3.4.21.39 N-benzyl-6-(5-chloro-2-methoxybenzyl)-3,7-dioxo-1,4-diazepane-1-carboxamide - 64869 3.4.21.39 N-benzyl-6-(5-chloro-2-methoxybenzyl)-N-methyl-3,7-dioxo-1,4-diazepane-1-carboxamide - 64870 3.4.21.39 N-substituted saccharin derivatives - 47403 3.4.21.39 N-tosyl-L-phenylalanyl-chloromethyl ketone - 39038 3.4.21.39 N-[2-[5-amino-2-(3-chloro-phenyl)-6-oxo-6H-pyrimidin-1-yl]-acetyl]-N,N'-dibenzyl-2,2-difluoro-malonamide novel, potent, and orally active inhibitor. Rapidly after oral administration and has satisfactory bioavailability, 32% 13487 3.4.21.39 N-[2-[5-amino-2-(3-chloro-phenyl)-6-oxo-6H-pyrimidin-1-yl]-acetyl]-N,N'-dibenzyl-2,2-difluoro-malonamide novel, potent, and orally active inhibitor. Rapidly after oral administration and has satisfactory bioavailability 13487 3.4.21.39 N-[2-[5-amino-2-(3-chloro-phenyl)-6-oxo-6H-pyrimidin-1-yl]-acetyl]-N,N'-dibenzyl-2,2-difluoro-malonamide novel, potent, and orally active inhibitor. Rapidly after oral administration and has satisfactory bioavailability, 17% 13487 3.4.21.39 NK-3201 - 151530 3.4.21.39 NK3201 - 36837 3.4.21.39 NK3201 specific inhibitor 36837 3.4.21.39 oleamide - 2593 3.4.21.39 oleic acid - 380 3.4.21.39 oleic acid reversible inhibitor 380 3.4.21.39 oleoyl lysophosphatidic acid - 101216 3.4.21.39 ONO-WH-236 40 and 80 mg/kg used experimentally, potent and selective inhibition of chymase activity 201654 3.4.21.39 palmitoyl lysophosphatidic acid - 21194 3.4.21.39 phenylmethylsulfonyl fluoride - 257 3.4.21.39 phosphatidic acid from bovine brain 491 3.4.21.39 phosphatidylethanolamine - 513 3.4.21.39 phosphatidylinositol - 473 3.4.21.39 phosphatidylserine - 430 3.4.21.39 phosphatidylserine noncompetitive, pseudoirreversible, strong inhibition at pH 8.5-9.5, weak inhibition below pH 7.5 430 3.4.21.39 platelet factor 4 i.e. PF-4, competitive inhibition of enzyme and cathepsin G 60781 3.4.21.39 proanthocyanidin - 239589 3.4.21.39 quercetin - 137 3.4.21.39 RO5066852 - 86217 3.4.21.39 rutin - 1095 3.4.21.39 RWJ-355871 - 58205 3.4.21.39 SD906 - 123126 3.4.21.39 secretory leucocyte protease inhibitor - 69503 3.4.21.39 secretory leukocyte protease inhibitor - 26668 3.4.21.39 SF-8257 - 201653 3.4.21.39 SF2809-I the inhibitor is isolated from the fermentation broth of Dactylosporangium sp., specific chymase inhibitor with little or no inhibitory activity against chymotrypsin or cathepsin G, IC50: 0.0073 mM 56029 3.4.21.39 SF2809-II the inhibitor is isolated from the fermentation broth of Dactylosporangium sp., specific chymase inhibitor with little or no inhibitory activity against chymotrypsin or cathepsin G, IC50: 0.000041 mM 56030 3.4.21.39 SF2809-III the inhibitor is isolated from the fermentation broth of Dactylosporangium sp., specific chymase inhibitor with little or no inhibitory activity against chymotrypsin or cathepsin G, IC50: 0.0021 mM 56031 3.4.21.39 SF2809-IV the inhibitor is isolated from the fermentation broth of Dactylosporangium sp., specific chymase inhibitor with little or no inhibitory activity against chymotrypsin or cathepsin G, IC50: 0.000081 56032 3.4.21.39 SF2809-V the inhibitor is isolated from the fermentation broth of Dactylosporangium sp., specific chymase inhibitor with little or no inhibitory activity against chymotrypsin or cathepsin G, IC50: 0.000043 mM 56033 3.4.21.39 SF2809-VI the inhibitor is isolated from the fermentation broth of Dactylosporangium sp., specific chymase inhibitor with little or no inhibitory activity against chymotrypsin or cathepsin G, IC50: 0.000014 mM 56034 3.4.21.39 SF2809E - 239591 3.4.21.39 soybean tryosin inhibitor - 123125 3.4.21.39 Soybean trypsin inhibitor - 544 3.4.21.39 Soybean trypsin inhibitor complete inhibition at 0.1 mg/ml 544 3.4.21.39 Soybean trypsin inhibitor Bowman-Birk soybean trypsin inhibitor; Kunitz soybean trypsin inhibitor, partial 544 3.4.21.39 stearic acid - 1359 3.4.21.39 stearic acid strong inhibition at pH 8.5-9.5, slight inhibition at pH 7.5, no inhibition at pH 6.0 1359 3.4.21.39 substituted 3-phenylsulfonylquinazoline-2,4-dione derivatives - 123127 3.4.21.39 Suc-Val-Pro-PheP-(OPh)2 noncompetitive inhibitor 18430 3.4.21.39 Suc-Val-Pro-PheP-(OPh)2 specific chymase inhibitor 18430 3.4.21.39 succinyl-Phe-Leu-Phe-phosphonate diphenyl ester - 101531 3.4.21.39 succinyl-Pro-Leu-Phe-CH2Cl - 31645 3.4.21.39 succinyl-Val-Pro-PheP(OPh)2 - 75342 3.4.21.39 succinyl-Val-Pro-PheP-(OPh)2 - 37015 3.4.21.39 succinyl-Val-Pro-PheP-(OPh)2 highly specific and metabolically stable chymase inhibitor with a biological half-life of more than 20 h 37015 3.4.21.39 succinyl-Val-Pro-PheP-(OPh)2 highly-specific and metabolically stable chymase inhibitor with a biological half-life of more than 20 h 37015 3.4.21.39 SUN C8077 - 201655 3.4.21.39 SUN C8257 - 151532 3.4.21.39 SUN-C8007 i.e. 3-(3-aminophenylsulfonyl)-7-chloroquinazorine-2,4(1H,3H)-dione 39037 3.4.21.39 SUN-C8007 i.e. 3-(3-aminophenylsulfonyl)-7-chloroquinazorine-2, 4(1H,3H)-dione 39037 3.4.21.39 SUN-C8257 i.e. 3-[(3-amino-4-carboxy)phenylsulfonyl]-7-chloroquinazorine 2,4(1H,3H)-dione 39033 3.4.21.39 SUN13350 - 151531 3.4.21.39 SUNC8257 - 139019 3.4.21.39 suramin i.e. 8,8'-[carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-1,3,5-naphthalenetrisulfonic acid 704 3.4.21.39 t-butyloxycarbonyl-Gly-Leu-Phe - 31647 3.4.21.39 tosyl-Phe-CH2Cl - 9283 3.4.21.39 Trypstatin partial 31158 3.4.21.39 TY-51184 highly-specific and orally active chymase inhibitor; i.e. 2-[4-(5-fluoro-3-methylbenzo[b]thiophen-2-yl)sulfonamide-3-methanesulfonylphenyl]oxazole-4-carboxylic acid 18355 3.4.21.39 TY-51184 highly-specific and orally-active chymase inhibitor; i.e. 2-[4-(5-fluoro-3-methylbenzo[b]thiophen-2-yl)sulfonamide-3-methanesulfonylphenyl]oxazole-4-carboxylic acid 18355 3.4.21.39 TY-51469 i.e. 2-[4-(5-fluoro-3-methylbenzo[b]thiophen-2-yl)sulfonamido-3-methanesulfonylphenyl]thiazole-4-carboxylic acid; inhibitor with very high affinity (IC50 0.1 nmol/kg) against chymase 14669 3.4.21.39 TY-51469 i.e. 2-[4-(5-fluoro-3-methylbenzo[b]thiophen-2-yl)sulfonamido-3-methanesulfonylphenyl]thiazole-4-carboxylic acid; inhibitor with very high affinity against chymase 14669 3.4.21.39 TY-51469 i.e. 2-[4-(5-fluoro-3-methylbenzo[b]thiophen-2-yl)sulfonamido-3-methanesulfonylphenyl]thiazole-4-carboxylic acid, TY-51469 has a high specificity for chymase 14669 3.4.21.39 TY-51469 specific chymase inhibitor, i.e. 2-[4-(5-fluoro-3-methylbenzo[b]thiophen-2-yl)sulfonamido-3-methanesulfonylphenyl]thiazole-4-carboxylic acid 14669 3.4.21.39 TY51184 - 138444 3.4.21.39 Y-40018 i.e. 4-[5-amino-2-(3-chlorophenyl)-6-oxo-1,6-dihydropyrimidin-1-ylacetamido]-N-benzyl-2,2-difluoro-3-oxo-5-phenylpentanamide 39040 3.4.21.39 Y-40079 i.e. 2-[2-[2-[5-amino-2-(3-methoxyphenyl)-6-oxo-1,6-dihydropyrimidin-1-yl]acetamido]-3-phenylpropionyl]benzoxazole-5-carboxylic acid methyl ester 39039 3.4.21.39 Z-Ile-Glu-Pro-Phe-CO2Me - 75343 3.4.21.39 [1-(1-benzofuran-3-yl)-2-(naphthalen-2-ylamino)-2-oxoethyl]phosphonic acid - 64929 3.4.21.39 [1-(1-benzothiophen-3-yl)-2-(naphthalen-2-ylamino)-2-oxoethyl]phosphonic acid - 64930 3.4.21.39 [1-(1-methyl-1H-indol-3-yl)-2-(naphthalen-2-ylamino)-2-oxoethyl]phosphonic acid - 64931 3.4.21.39 [1-(1H-indol-3-yl)-2-(naphthalen-2-ylamino)-2-oxoethyl]phosphonic acid - 66432 3.4.21.39 [1-(2,3-dihydro-1H-benzotriazol-1-yl)-2-(naphthalen-2-ylamino)-2-oxoethyl]phosphonic acid less than 50% inhibition at 0.01 mM 138450 3.4.21.39 [1-(5-chloro-1-benzothiophen-3-yl)-2-(naphthalen-2-ylamino)-2-oxoethyl](2-phenylethyl)phosphinic acid - 64932 3.4.21.39 [1-(5-chloro-1-benzothiophen-3-yl)-2-(naphthalen-2-ylamino)-2-oxoethyl]ethylphosphinic acid - 64933 3.4.21.39 [1-(5-chloro-1-benzothiophen-3-yl)-2-(naphthalen-2-ylamino)-2-oxoethyl]methylphosphinic acid - 64934 3.4.21.39 [1-(5-chloro-1-benzothiophen-3-yl)-2-(naphthalen-2-ylamino)-2-oxoethyl]phenylphosphinic acid - 64935 3.4.21.39 [1-(5-chloro-1-benzothiophen-3-yl)-2-(naphthalen-2-ylamino)-2-oxoethyl]phosphonic acid - 64936 3.4.21.39 [1-(5-chloro-1-benzothiophen-3-yl)-2-oxo-2-[[(E)-2-phenylethenyl]amino]ethyl]methylphosphinic acid - 64937 3.4.21.39 [1-(5-chloro-1-benzothiophen-3-yl)-2-oxo-2-[[(E)-2-phenylethenyl]amino]ethyl]phosphonic acid - 64938 3.4.21.39 [1-(5-chloro-1-benzothiophen-3-yl)-2-[[(E)-2-(3,4-difluorophenyl)ethenyl]amino]-2-oxoethyl]ethylphosphinic acid - 64939 3.4.21.39 [1-(5-chloro-1-benzothiophen-3-yl)-2-[[(E)-2-(3,4-difluorophenyl)ethenyl]amino]-2-oxoethyl]methylphosphinic acid - 64940 3.4.21.39 [1-(5-chloro-1-benzothiophen-3-yl)-2-[[(E)-2-(3,4-difluorophenyl)ethenyl]amino]-2-oxoethyl]phosphonic acid - 64941 3.4.21.39 [1-(5-chloro-1-benzothiophen-3-yl)-2-[[(E)-2-(3-chloro-5-fluorophenyl)ethenyl]amino]-2-oxoethyl]methylphosphinic acid - 64942 3.4.21.39 [1-(5-chloro-1-benzothiophen-3-yl)-2-[[(E)-2-(3-chlorophenyl)ethenyl]amino]-2-oxoethyl]methylphosphinic acid - 64943 3.4.21.39 [1-(5-chloro-1-benzothiophen-3-yl)-2-[[(E)-2-(4-fluorophenyl)ethenyl]amino]-2-oxoethyl]phosphonic acid - 64944 3.4.21.39 [1-(5-chloro-1-benzothiophen-3-yl)-2-[[(E)-2-(4-methoxyphenyl)ethenyl]amino]-2-oxoethyl]phosphonic acid - 64945 3.4.21.39 [1-(5-chloro-1-benzothiophen-3-yl)-2-[[2-(3,4-difluorophenyl)ethyl]amino]-2-oxoethyl]methylphosphinic acid - 64946 3.4.21.39 [1-(5-chloro-1-methyl-1H-indol-3-yl)-2-(naphthalen-2-ylamino)-2-oxoethyl]methylphosphinic acid - 64947 3.4.21.39 [1-(5-chloro-1-methyl-1H-indol-3-yl)-2-(naphthalen-2-ylamino)-2-oxoethyl]phosphonate - 200421 3.4.21.39 [1-(5-chloro-1-methyl-1H-indol-3-yl)-2-(naphthalen-2-ylamino)-2-oxoethyl]phosphonic acid - 64948 3.4.21.39 [1-(5-chloro-1-methyl-1H-indol-3-yl)-2-[[(E)-2-(3,4-difluorophenyl)ethenyl]amino]-2-oxoethyl]methylphosphinic acid - 64949 3.4.21.39 [1-(5-chloro-1-methyl-1H-indol-3-yl)-2-[[(E)-2-(4-fluorophenyl)ethenyl]amino]-2-oxoethyl]phosphonic acid - 64950 3.4.21.39 [1-naphthalen-1-yl-2-(naphthalen-2-ylamino)-2-oxoethyl]phosphonic acid - 64951 3.4.21.39 [1-[(1-Benzyl-2-hydroxy-2-oxazolo[5,4-b]pyridin-2-yl-ethylcarbamoyl)-methyl]-2-(4-fluoro-phenyl)-6-oxo-1,6-dihydro-pyrimidin-5-yl]-carbamic acid benzyl ester - 55233 3.4.21.39 [2-(3-[methyl[1-(naphthalen-2-ylcarbonyl)piperidin-4-yl]carbamoyl]naphthalen-2-yl)-1-naphthalen-1-yl-2-oxoethyl]phosphonic acid - 64952 3.4.21.39 [4-chloro-2-([1-[(4-chlorophenyl)sulfonyl]-3,7-dioxo-1,4-diazepan-6-yl]methyl)phenoxy]acetic acid - 64959